Identification of new prognostic biomarkers for Stage III metastatic melanoma patients

por Kakavand, Hojabr, Scolyer, Richard A, Thompson, John F, Mann, Graham J
Publicado 2013

Differential distribution improves gene selection stability and has competitive classification performance for patient survival

por Strbenac, Dario, Mann, Graham J., Yang, Jean Y.H., Ormerod, John T.
Publicado 2016

Network-based biomarkers enhance classical approaches to prognostic gene expression signatures

por Barter, Rebecca L, Schramm, Sarah-Jane, Mann, Graham J, Yang, Yee Hwa
Publicado 2014

VAN: an R package for identifying biologically perturbed networks via differential variability analysis

por Jayaswal, Vivek, Schramm, Sarah-Jane, Mann, Graham J, Wilkins, Marc R, Yang, Yee Hwa
Publicado 2013

Variation in the RAD51 gene and familial breast cancer

por Lose, Felicity, Lovelock, Paul, Chenevix-Trench, Georgia, Mann, Graham J, Pupo, Gulietta M, Spurdle, Amanda B
Publicado 2006

The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study

por Howard, Kirsten, Salkeld, Glenn P, Mann, Graham J, Patel, Manish I, Cunich, Michelle, Pignone, Michael P
Publicado 2012

A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types

por Patrick, Ellis, Schramm, Sarah-Jane, Ormerod, John T, Scolyer, Richard A, Mann, Graham J, Mueller, Samuel, Yang, Jean Y.H.
Publicado 2016

Screening for obstructive sleep apnoea in post‐treatment cancer patients

por Subramanian, Harini, Fuchsova, Veronika, Elder, Elisabeth, Brand, Alison, Howle, Julie, DeFazio, Anna, Mann, Graham J., Amis, Terence, Kairaitis, Kristina
Publicado 2022

Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk

por Law, Matthew H., Montgomery, Grant W., Brown, Kevin M., Martin, Nicholas G., Mann, Graham J., Hayward, Nicholas K., MacGregor, Stuart
Publicado 2011

The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease

por Dieng, Mbathio, Kasparian, Nadine A., Morton, Rachael L., Mann, Graham J., Butow, Phyllis, Menzies, Scott, Costa, Daniel S.J., Cust, Anne E.
Publicado 2015

Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review

por Blood, Zachary, Tran, Anh, Caleo, Lauren, Saw, Robyn, Dieng, Mbathio, Shackleton, Mark, Soyer, H Peter, Arnold, Chris, Mann, Graham J, Morton, Rachael L
Publicado 2021

BCoR-L1 variation and breast cancer

por Lose, Felicity, Arnold, Jeremy, Young, David B, Brown, Carolyn J, Mann, Graham J, Pupo, Gulietta M, Khanna, Kum Kum, Chenevix-Trench, Georgia, Spurdle, Amanda B
Publicado 2007

Correction: BCoR-L1 variation and breast cancer

por Lose, Felicity, Arnold, Jeremy, Young, David B, Brown, Carolyn J, Mann, Graham J, Pupo, Gulietta M, Khanna, Kum Kum, Chenevix-Trench, Georgia, Spurdle, Amanda B
Publicado 2008

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

por Krisp, Christoph, Parker, Robert, Pascovici, Dana, Hayward, Nicholas K., Wilmott, James S., Thompson, John F., Mann, Graham J., Long, Georgina V., Scolyer, Richard A., Molloy, Mark P.
Publicado 2018

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

por Marsh, Anna, Spurdle, Amanda B, Turner, Bruce C, Fereday, Sian, Thorne, Heather, Pupo, Gulietta M, Mann, Graham J, Hopper, John L, Sambrook, Joseph F, Chenevix-Trench, Georgia
Publicado 2001

Cancer sleep symptom‐related phenotypic clustering differs across three cancer specific patient cohorts

por Kairaitis, Kristina, Madut, Ayey S., Subramanian, Harini, Trivedi, Ritu, Man, Hong, Mather, Marius, Brand, Alison, Elder, Elisabeth, Howle, Julie, Mann, Graham J, Amis, Terence C., De Fazio, Anna
Publicado 2022

The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16(INK4a)

por Becker, Therese M, Haferkamp, Sebastian, Dijkstra, Menno K, Scurr, Lyndee L, Frausto, Monika, Diefenbach, Eve, Scolyer, Richard A, Reisman, David N, Mann, Graham J, Kefford, Richard F, Rizos, Helen
Publicado 2009

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients

por Kaufman, Kimberley L., Mactier, Swetlana, Armstrong, Nicola J., Mallawaaratchy, Duthika, Byrne, Scott N., Haydu, Lauren E., Jakrot, Valerie, Thompson, John F., Mann, Graham J., Scolyer, Richard A., Christopherson, Richard I.
Publicado 2014

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients

por Mactier, Swetlana, Kaufman, Kimberley L, Wang, Penghao, Crossett, Ben, Pupo, Gulietta M, Kohnke, Philippa L, Thompson, John F, Scolyer, Richard A, Yang, Jean Y, Mann, Graham J, Christopherson, Richard I
Publicado 2014

Identifying the ‘Active Ingredients' of an Effective Psychological Intervention to Reduce Fear of Cancer Recurrence: A Process Evaluation

por Kan, Janice M., Dieng, Mbathio, Butow, Phyllis N., Mireskandari, Shab, Tesson, Stephanie, Menzies, Scott W., Costa, Daniel S. J., Morton, Rachael L., Mann, Graham J., Cust, Anne E., Kasparian, Nadine A.
Publicado 2021